logo
  

Cochlear To Immediately Begin Controlled Market Release Of Remote Assist In The U.S.

Cochlear Limited has received FDA approval in September for the company's Cochlear Remote Assist solution in the Nucleus and Baha Systems. Cochlear noted that the FDA approval for the implant solution and FDA clearance for the Baha solution are the first step in commercializing the product offering, anticipated spring 2022.

Cochlear said it will immediately begin a controlled market release of Remote Assist in the U.S. by partnering with hearing healthcare providers and hospitals.

The company expects Remote Assist approval in Canada in late 2021 for the Nucleus System and early 2022 for the Baha System.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
McDonald's says equal pay for women is just the beginning, while conforming that the fast-food giant pays women globally 99.85 cents on the dollar for similar work, taking into account legitimate pay drivers such as level, location, experience, and performance. The company added that it is on track to close that identified gap in 2022. Verizon Communications Inc. (VZ) said, on an adjusted basis, its third-quarter earnings per share rose 12.8 percent from a year ago. The company said its earnings were highlighted by revenue and customer growth as more than one in four Consumer wireless phone customers now have a 5G-capable device. The... While reporting financial results for the third quarter on Wednesday, Abbott Laboratories (ABT) raised its earnings and adjusted earnings guidance for the full-year 2021. For fiscal 2021, the company continues to project earnings from continuing operations in a range of $3.55 to $3.6 per share and...
RELATED NEWS
Follow RTT